Analysis and Limitation of Parasitic Diseases
The management of parasitic diseases of humans has been undertaken since the cause and history of the infections was recognized. Some parasitic infections like protozoa infection have tried tough to regulate. Worm infections are effectively controlled.
They are totally different approaches to regulate from designation to treatment of parasitic diseases. The transmission by preventative therapy and vector control. Then incontrovertible fact that the unfold of the many parasitic diseases are by contaminated provides ensuing from inadequate waste disposal.
- Treatment and Control
- Treatment of Parasitic Diseases
- Vaccines for Parasitic Diseases
Related Conference of Analysis and Limitation of Parasitic Diseases
March 09-10, 2026
21th International Conference on Allergic Diseases and Clinical Immunology
Singapore City, Singapore
April 16-17, 2026
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
London, UK
Analysis and Limitation of Parasitic Diseases Conference Speakers
Recommended Sessions
- Analysis and Limitation of Parasitic Diseases
- Anatomical Parasitology
- Animal Associations
- Approaches to Control Parasitic Diseases
- Arthropod Parasites
- Basic Parasitology
- Benefits of Parasites
- Cataloging of Parasites
- Epidemiology of Bacterial Infections
- Equatorial Parasitology
- Experimental Parasitology
- Health Policy Environment
- Helminthology
- Immunoparasitology
- Marine Parasites and Exposure to Public Health
- Molecular Biology and Immune Evasion
- Nourishment and Biochemistry of Parasites
- Parasitic Host
- Protozoology
- Recombinant DNA Technology on Parasitology
- Remunerative for Parasite Diseases
- Scientific Manifestations of Parasitic Diseases
- Tested Parasitology
- Therapeutic Parasitology
- Ticks and Tick-Borne Diseases
- Transmission of Parasitic Infection
- Vector-Borne Diseases
- Veterinary Parasitology
Related Journals
Are you interested in
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Infectious Diseases - Antibiotics 2026 (UK)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)